Key result
Zero-fluoroscopy catheter ablation achieves 100% acute success with no complications in congenital heart disease.
Why the study?
Radiation-free catheter ablation is feasible with modern electroanatomic mapping systems, but its feasibility, safety, and outcomes in patients with congenital heart disease required evaluation.
Observational (n=42)
No
Zero-fluoroscopy catheter ablation of arrhythmias using 3D electroanatomic mapping is feasible, safe, and highly effective in select patients across a spectrum of congenital heart disease complexities.
Answers are grounded in this paper and cite their sources.
Supports feasibility of zero-fluoroscopy ablation in congenital heart disease; leaves open need for randomized trials to confirm durability.
Aims: Radiation-free catheter ablation is feasible with modern electroanatomic mapping systems. We aimed to evaluate the feasibility, safety, and outcomes of non-fluoroscopic ablation (NFA) in patients with congenital heart disease (CHD). Methods: We retrospectively reviewed CHD patients who underwent NFA between November 2016 and January 2025. All procedures were performed using the CARTO 3D electroanatomic mapping system. Atrial, ventricular, and aortic geometries were reconstructed as needed. Catheter navigation and sheath placement were guided without fluoroscopy; intracardiac echocardiography was used selectively. Results: Forty-two patients (23 females) with CHD underwent NFA. The median age was 14 years (range 4-56), and median weight was 55 kg (range 19-145). Twenty-one patients had mild, 16 moderate complexity and 5 great complexity CHD. Arrhythmia mechanisms included AVNRT (14%), manifest WPW (21%), high-risk WPW without SVT (5%), concealed pathway AVRT (26%), AFL (12%), AT (14%), and VT (7%). Two patients had both AVNRT and AVRT. Acute success was achieved in all cases without fluoroscopy or acute complications. Over a median 48-month follow-up, three patients had recurrences: one with WPW and Ebstein anomaly, one with ASD/PLSVC and concealed pathway, and one with dual arrhythmia substrates. Conclusion: Zero-fluoroscopy ablation of arrhythmias in select patients with mild moderate or great complexity CHD is feasible, safe, and effective, offering high acute success and low recurrence while eliminating radiation exposure.
No takes yet. Share an insight, caveat, or question.
Upadhyay et al. (2025) conducted an observational in Congenital heart disease with arrhythmias (n=42). Zero-fluoroscopy catheter ablation using CARTO 3D electroanatomic mapping was evaluated on Acute procedural success (complete non-inducibility of targeted arrhythmia). Zero-fluoroscopy catheter ablation achieved a 100% acute success rate with no acute complications in patients with mild to great complexity congenital heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: